Journal
FUTURE MEDICINAL CHEMISTRY
Volume 15, Issue 16, Pages 1527-1548Publisher
Newlands Press Ltd
DOI: 10.4155/fmc-2023-0138
Keywords
anticancer; azole; hybrid; imidazole; isoxazole; mechanism of action; oxazole; pyrazole; structure-activity relationship; thiazole; triazole
Categories
Ask authors/readers for more resources
This article highlights the recent advances in pyrazole-azole hybrids with anticancer potential, discussing the structure-activity relationships to facilitate the rational design of more effective anticancer candidates.
Chemotherapy is a critical treatment modality for cancer patients, but multidrug resistance remains one of the major challenges in cancer therapy, creating an urgent need for the development of novel potent chemical entities. Azoles, particularly pyrazole, could interact with different biological targets and exhibit diverse biological properties including anticancer activity. Many clinically used anticancer agents own an azole moiety, demonstrating that azoles are privileged and pivotal templates in the discovery of novel anticancer chemotherapeutics. The present article is an attempt to highlight the recent advances in pyrazole-azole hybrids with anticancer potential and discuss the structure-activity relationships, covering articles published from 2018 to present, to facilitate the rational design of more effective anticancer candidates.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available